
Idera Pharmaceuticals IDRA
Quartalsbericht 2023-Q1
hinzugefügt 29.06.2023
Idera Pharmaceuticals Kurzfristige Verbindlichkeiten 2011-2026 | IDRA
Kurzfristige Verbindlichkeiten Jährlich Idera Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.4 M | 4.86 M | 7.03 M | 54.5 M | 9.02 M | 10.1 M | 9.35 M | 6.82 M | 7.05 M | 4.41 M | 4.13 M | 6.08 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 54.5 M | 4.13 M | 12.1 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AbCellera Biologics
ABCL
|
64.3 M | $ 3.54 | -0.7 % | $ 1.06 B | ||
|
Acorda Therapeutics
ACOR
|
228 M | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
1.93 M | - | 4.01 % | $ 150 M | ||
|
Advaxis
ADXS
|
25 M | - | -9.65 % | $ 45.9 M | ||
|
I-Mab
IMAB
|
576 M | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
58.7 M | - | - | $ 1.01 B | ||
|
AgeX Therapeutics
AGE
|
5.91 M | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
45.3 M | - | -0.23 % | $ 916 M | ||
|
Aileron Therapeutics
ALRN
|
5.75 M | - | 10.36 % | $ 9.8 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M | - | -1.52 % | $ 24.7 M | ||
|
Aptorum Group Limited
APM
|
4.34 M | $ 0.8 | 1.81 % | $ 4.36 M | ||
|
Adverum Biotechnologies
ADVM
|
22.9 M | - | - | $ 86.2 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
25.2 M | - | - | $ 26.5 M | ||
|
Applied Molecular Transport
AMTI
|
15.1 M | - | - | $ 10.1 M | ||
|
Atea Pharmaceuticals
AVIR
|
39.8 M | $ 6.15 | 1.57 % | $ 501 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
36.4 M | $ 6.62 | -0.15 % | $ 181 M | ||
|
BioCardia
BCDA
|
3.61 M | $ 1.35 | 6.29 % | $ 28.6 M | ||
|
Институт стволовых клеток человека
ISKJ
|
556 M | - | - | - | ||
|
Akero Therapeutics
AKRO
|
39.8 M | - | - | $ 3.67 B | ||
|
Athersys
ATHX
|
29.9 M | - | 3.77 % | $ 22.4 M | ||
|
Akouos
AKUS
|
16.8 M | - | 0.23 % | $ 488 M | ||
|
Acer Therapeutics
ACER
|
19 M | - | 2.71 % | $ 14 M | ||
|
ARCA biopharma
ABIO
|
13 M | - | 1052.0 % | $ 415 M | ||
|
Allena Pharmaceuticals
ALNA
|
15.7 M | - | 3.16 % | $ 1.9 M | ||
|
AlloVir
ALVR
|
5.24 M | - | 4.14 % | $ 49.1 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
2.05 M | $ 3.58 | -0.28 % | $ 7.79 B | ||
|
Catalyst Biosciences
CBIO
|
18.3 M | $ 11.29 | -2.51 % | $ 1.01 B | ||
|
Anika Therapeutics
ANIK
|
31.1 M | $ 14.58 | 1.53 % | $ 214 M | ||
|
Aptinyx
APTX
|
6.29 M | - | -39.0 % | $ 4.57 M | ||
|
Aptose Biosciences
APTO
|
4.46 M | - | -45.71 % | $ 1.2 M | ||
|
CNS Pharmaceuticals
CNSP
|
2.52 M | $ 2.32 | -5.51 % | $ 887 K | ||
|
AVEO Pharmaceuticals
AVEO
|
18.7 M | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
7.54 M | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
63.1 M | $ 2.69 | 1.7 % | $ 16.9 M | ||
|
Curis
CRIS
|
19 M | $ 0.89 | 3.74 % | $ 5.61 M | ||
|
Avenue Therapeutics
ATXI
|
816 K | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
60.7 M | $ 1.51 | -0.33 % | $ 385 M | ||
|
Athira Pharma
ATHA
|
13.1 M | - | - | $ 269 M |